It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Supercritical fluids (SCFs) can be used to prepare drugs nanoparticles with improved solubility. SCFs have shown superior advantages in pharmaceutical industry as an environmentally friendly alternative to toxic/harmful organic solvents. They possess gas-like transport characteristics and liquid-like solvation power for solutes. Evaluation of chemotherapeutic drugs’ solubility in supercritical carbon dioxide (SCCO2) has been recently an attractive subject for developing this method in pharmaceutical sector. To reach this purpose, the utilization of accurate models is of great necessity to estimate experimental-based solubility data. In this paper, the authors tried to employ machine learning (ML) approaches to estimate the solubility of Letrozole (LET) drug as chemotherapeutic agent and correlate its values in wide ranges of temperature and pressure. To do this, PAR (Passive Aggressive Regression), RF (Random Forest), and RBF-SVM are the models used (Support Vector Machine with RBF kernel). These models optimized in terms of their hyper-parameters using GA algorithm. The optimized PAR, RF, RBF-SVM models obtained coefficients of determination (R-squared) of 0.8277, 0.9534, and 0.9947. Also, the MSE error rate of the models are 0.1342, 0.0305, and 0.0045, in the same order. The final result of the evaluations shows the optimized RBF-SVM model as the most appropriate model in this research. The model exhibits a maximum prediction error of 0.1289.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Taif University, Department of Pharmaceutical Chemistry, College of Pharmacy, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255)
2 Taif University, Department of Oral & Maxillofacial Surgery and Diagnostic Sciences, Faculty of Dentistry, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255)
3 Taif University, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255)
4 Taif University, Department of Preventive Dentistry, Faculty of Dentistry, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255)
5 Taif University, Department of Restorative Dental Science, Faculty of Dentistry, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255)